At Holdings Channel , we have reviewed the latest batch of the 29 most recent 13F filings for the 09/30/2015 reporting period, and noticed that Bristol-Myers Squibb Co. (Symbol: BMY) was held by 17 of these funds. When hedge fund managers appear to be thinking alike, we find it is a good idea to take a closer look.
Before we proceed, it is important to point out that 13F filings do not tell the whole story, because these funds are only required to disclose their long positions with the SEC, but are not required to disclose their short positions. A fund making a bearish bet against a stock by shorting calls, for example, might also be long some amount of stock as they trade around their overall bearish position. This long component could show up in a 13F filing and everyone might assume the fund is bullish, but this tells only part of the story because the bearish/short side of the position is not seen .
Having given that caveat, we believe that looking at groups of 13F filings can be revealing, especially when comparing one holding period to another. Below, let's take a look at the change in BMY positions, for this latest batch of 13F filers:
Change In Share Count
Change In Market Value($ in 1000's)
Stanley Laman Group Ltd.
Oxbow Advisors LLC
Stratford Consulting LLC
CG Asset Management LLC
Bbva Compass Bancshares Inc.
Buckhead Capital Management LLC
Boys Arnold & Co. Inc.
Oxbow Advisors LLC
Financial Management Professionals Inc.
Thompson Siegel & Walmsley LLC
Tiemann Investment Advisors LLC
Karp Capital Management Corp
Lee Danner & Bass Inc.
Covington Investment Advisors Inc.
Mathes Company Inc.
In terms of shares owned, we count 7 of the above funds having increased existing BMY positions from 06/30/2015 to 09/30/2015, with 6 having decreased their positions.
Looking beyond these particular funds in this one batch of most recent filers, we tallied up the BMY share count in the aggregate among all of the funds which held BMY at the 09/30/2015 reporting period (out of the 1,098 we looked at in total). We then compared that number to the sum total of BMY shares those same funds held back at the 06/30/2015 period, to see how the aggregate share count held by hedge funds has moved for BMY. We found that between these two periods, funds increased their holdings by 460,163 shares in the aggregate, from 72,460,450 up to 72,920,613 for a share count increase of approximately 0.64%. The overall top three funds holding BMY on 09/30/2015 were:
We'll keep following the latest 13F filings by hedge fund managers and bring you interesting stories derived from a look at the aggregate information across groups of managers between filing periods. While looking at individual 13F filings can sometimes be misleading due to the long-only nature of the information, the sum total across groups of funds from one reporting period to another can be a lot more revealing and relevant, providing interesting stock ideas that merit further research, like Bristol-Myers Squibb Co. (Symbol: BMY).